Zai Lab (ZLAB) Assets Average (2017 - 2026)
Zai Lab's (ZLAB) quarterly Assets Average came in at $1.1 billion in Q1 2026, down 3.86% year-on-year from $1.2 billion in Q1 2025, and down 2.71% quarter-over-quarter from $1.2 billion in Q4 2025.
Zai Lab (ZLAB) Assets Average (2017 - 2026) Analysis & Trends
Zai Lab has disclosed Assets Average across 9 years of filings, most recently posting $1.1 billion for Q1 2026.
- Assets Average for Q1 2026 came in at $1.1 billion, down 3.86% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.1 billion (down 3.86% YoY), and the FY2025 annual result was $1.2 billion, up 6.12% from the prior year.
- Assets Average came in at $1.1 billion for Q1 2026 at Zai Lab, down from $1.2 billion in the prior quarter.
- In the past five years, Assets Average ranged from a high of $1.6 billion in Q1 2022 to a low of $986.4 million in Q3 2024.
- The 5-year median for Assets Average is $1.2 billion (2025), against an average of $1.2 billion.
- Peak annual rise in Assets Average reached 28.08% in 2022, while the deepest fall reached 25.0% in 2022.
- Zai Lab's Assets Average stood at $1.3 billion in 2022, then slipped by 17.42% to $1.0 billion in 2023, then increased by 4.38% to $1.1 billion in 2024, then increased by 7.38% to $1.2 billion in 2025, then retreated by 2.71% to $1.1 billion in 2026.
- The last three Assets Average figures came in at $1.1 billion (Q1 2026), $1.2 billion (Q4 2025), and $1.2 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 33.42 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 795.91 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13.04 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.72 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 26.03 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 40.89 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 10.06 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 26.06 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 660.38 Mn |
| 10 | Zai Lab | 20.15 Bn | 20.05 Bn | 61.30 Mn | 1.13 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.13 Bn |
| Dec 31, 2025 | 1.17 Bn |
| Sep 30, 2025 | 1.16 Bn |
| Jun 30, 2025 | 1.17 Bn |
| Mar 31, 2025 | 1.18 Bn |
| Dec 31, 2024 | 1.09 Bn |
| Sep 30, 2024 | 986.36 Mn |
| Jun 30, 2024 | 987.90 Mn |
| Mar 31, 2024 | 1.01 Bn |
| Dec 31, 2023 | 1.04 Bn |
| Sep 30, 2023 | 1.08 Bn |
| Jun 30, 2023 | 1.14 Bn |
| Mar 31, 2023 | 1.20 Bn |
| Dec 31, 2022 | 1.26 Bn |
| Sep 30, 2022 | 1.36 Bn |
| Jun 30, 2022 | 1.46 Bn |
| Mar 31, 2022 | 1.56 Bn |
| Dec 31, 2021 | 1.67 Bn |
| Sep 30, 2021 | 1.81 Bn |
| Jun 30, 2021 | 1.51 Bn |